Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154432 | SCV000204100 | likely benign | not specified | 2014-04-09 | criteria provided, single submitter | clinical testing | Arg165Trp in exon 4 of LDB3: This variant is not expected to have clinical signi ficance due to a lack of conservation across species, including mammals. Of note , at least 7 mammals have a tryptophan (Trp) at this position. Additionally, it has been identified in 1/8592 European American chromosomes by the NHLBI Exome S equencing Project (http://evs.gs.washington.edu/EVS/) and in 1/38 Asian chromoso mes from the Coriell Cell Repository (dbSNP rs45610637). |
Gene |
RCV001719955 | SCV000235978 | likely benign | not provided | 2019-02-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621354 | SCV000736730 | likely benign | Cardiovascular phenotype | 2020-12-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000861221 | SCV001001478 | benign | Myofibrillar myopathy 4 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171121 | SCV001333801 | benign | Cardiomyopathy | 2019-02-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154432 | SCV002548434 | likely benign | not specified | 2022-05-02 | criteria provided, single submitter | clinical testing |